Showing results (1-10 of 355) with videos related to
Sort By:
Pageof 36
Expert Review of Proteomics|May 10, 2008
Alpha-synuclein and Parkinson's disease: a proteomic viewMauro Fasano, Leonardo LopianoJournal of Neurochemistry|January 19, 2006
Modifications of the iron-neuromelanin system in Parkinson's diseaseMauro Fasano, Bruno Bergamasco, Leonardo LopianoBiomarkers in Medicine|May 19, 2010
Peripheral biomarkers of Parkinson's disease as early reporters of central neurodegenerationMauro Fasano, Tiziana Alberio, Leonardo LopianoThe FEBS Journal|February 9, 2012
Cellular models to investigate biochemical pathways in Parkinson's diseaseTiziana Alberio, Leonardo Lopiano, Mauro FasanoProteomics. Clinical Applications|December 8, 2010
The proteomic approach in Parkinson's diseaseMauro Fasano, Bruno Bergamasco, Leonardo LopianoParkinsonism & Related Disorders|July 1, 2008
Proteomics as a tool to investigate cell models for dopamine toxicityMauro Fasano, Tiziana Alberio, Monica Colapinto, et al.Neurochemistry International|February 20, 2003
Residual substantia nigra neuromelanin in Parkinson's disease is cross-linked to alpha-synucleinMauro Fasano, Sabrina Giraudo, Silvia Coha, et al.Proteomics|November 5, 2004
Proteome analysis of human substantia nigra in Parkinson's diseaseManuela Basso, Sabrina Giraudo, Davide Corpillo, et al.IUBMB Life|March 13, 2010
Binding of anti-Parkinson's disease drugs to human serum albumin is allosterically modulatedGabriella Fanali, Viviana Rampoldi, Alessandra di Masi, et al.Scientific Reports|December 13, 2012
Discovery and verification of panels of T-lymphocyte proteins as biomarkers of Parkinson's diseaseTiziana Alberio, Agnese C Pippione, Maurizio Zibetti, et al.Pageof 36